Documenting the Benefits and Cost Savings of a Large Multistate Cancer Pathway Program From a Payer's Perspective
- 1 September 2013
- journal article
- health care-delivery
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 9 (5), e241-e247
- https://doi.org/10.1200/jop.2012.000871
Abstract
Broadly implemented clinical pathways can achieve reasonable physician compliance, resulting in substantial cost savings.Keywords
This publication has 25 references indexed in Scilit:
- Benchmarks for Value in Cancer Care: An Analysis of a Large Commercial PopulationJournal of Oncology Practice, 2011
- Pathways, Outcomes, and Costs in Colon Cancer: Retrospective Evaluations in Two Distinct DatabasesJournal of Oncology Practice, 2011
- Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community SettingJournal of Oncology Practice, 2010
- Limits on Medicare's Ability to Control Rising Spending on Cancer DrugsThe New England Journal of Medicine, 2009
- Step by step development of clinical care pathways for older cancer patients: Necessary or desirable?European Journal of Cancer, 2007
- Cost of Cancer Care: Issues and ImplicationsJournal of Clinical Oncology, 2007
- Reducing clinical variations with clinical pathways: do pathways work?International Journal for Quality in Health Care, 2003
- Critical Pathways as a Strategy for Improving Care: Problems and PotentialAnnals of Internal Medicine, 1995
- Critical Path Method: An Important Tool for Coordinating Clinical CareThe Joint Commission Journal on Quality Improvement, 1993
- Medical Care Costs: How Much Welfare Loss?Journal of Economic Perspectives, 1992